Gene · 150094
Papers4,535
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,535
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer. | J Transl Med | 2023 | 38082307 | PubTator, text mining | PubMed |
| A secure cross-domain interaction scheme for blockchain-based intelligent transportation systems. | PeerJ Comput Sci | 2023 | 38077614 | PubTator, text mining | PubMed |
| Utilizing CD44v6 and V600EBRAF-mutation for in vitro targeted combination therapy of thyroid carcinomas. | Heliyon | 2023 | 38076095 | PubTator, text mining | PubMed |
| Plasma proteomics-based biomarkers for predicting response to mesenchymal stem cell therapy in severe COVID-19. | Stem Cell Res Ther | 2023 | 38072927 | PubTator, text mining | PubMed |
| History of Parkinson's Disease-Associated Gene, Parkin: Research over a Quarter Century in Quest of Finding the Physiological Substrate. | Int J Mol Sci | 2023 | 38069057 | PubTator, text mining | PubMed |
| Identification of Tumor-Suppressive miR-139-3p-Regulated Genes: TRIP13 as a Therapeutic Target in Lung Adenocarcinoma. | Cancers (Basel) | 2023 | 38067275 | PubTator, text mining | PubMed |
| Stefin B Inhibits NLRP3 Inflammasome Activation via AMPK/mTOR Signalling. | Cells | 2023 | 38067160 | PubTator, text mining | PubMed |
| Local Recurrent Melanoma Treated with BRAF and MEK Inhibitors Despite Adjuvant Anti-Programmed Cell Death Protein 1 Antibody Therapy. | Ann Dermatol | 2023 | 38061750 | PubTator, text mining | PubMed |
| Study of the binding of ΔFN3.1 fragments of the Bifidobacterium longum GT15 with TNFα and prevalence of domain-containing proteins in groups of bacteria of the human gut microbiota. | Microbiome Res Rep | 2023 | 38047275 | PubTator, text mining | PubMed |
| A comparative study on ctDNA and tumor DNA mutations in lung cancer and benign cases with a high number of CTCs and CTECs. | J Transl Med | 2023 | 38041139 | PubTator, text mining | PubMed |
| The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma. | Diagn Pathol | 2023 | 38037110 | PubTator, text mining | PubMed |
| M6A RNA methylation modification and tumor immune microenvironment in lung adenocarcinoma. | Biophys Rep | 2023 | 38028153 | PubTator, text mining | PubMed |
| A2BR facilitates the pathogenesis of H. pylori-associated GU by inducing oxidative stress through p38 MAPK phosphorylation. | Heliyon | 2023 | 38027590 | PubTator, text mining | PubMed |
| Acryl-3,5-bis(2,4-difluorobenzylidene)-4-piperidone targeting cellular JUN proto-oncogene, AP-1 transcription factor subunit inhibits head and neck squamous cell carcinoma progression. | Explor Target Antitumor Ther | 2023 | 38023989 | PubTator, text mining | PubMed |
| Glucose transporter 1 deficiency, AMP-activated protein kinase activation and immune dysregulation in autism spectrum disorder: Novel biomarker sources for clinical diagnosis. | Saudi J Biol Sci | 2023 | 38020228 | PubTator, text mining | PubMed |
| Synthesis, biological evaluation and in silico investigations of benzotriazole derivatives as potential inhibitors of NIMA related kinase. | RSC Adv | 2023 | 38020022 | PubTator, text mining | PubMed |
| PoSSuM v.3: A Major Expansion of the PoSSuM Database for Finding Similar Binding Sites of Proteins. | J Chem Inf Model | 2023 | 38016694 | PubTator, text mining | PubMed |
| Bee Venom and Its Two Main Components-Melittin and Phospholipase A2-As Promising Antiviral Drug Candidates. | Pathogens | 2023 | 38003818 | PubTator, text mining | PubMed |
| Satellite mapping of red snow on North American glaciers. | Sci Adv | 2023 | 38000025 | PubTator, text mining | PubMed |
| Recent Advances in the Field of Artificial Intelligence for Precision Medicine in Patients with a Diagnosis of Metastatic Cutaneous Melanoma. | Diagnostics (Basel) | 2023 | 37998619 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/150094/papers?page=15